Castleview Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-191
Closed -$13.2K 584
2024
Q3
$13.2K Buy
191
+57
+43% +$3.68K 0.01% 515
2024
Q2
$8.55K Buy
134
+70
+109% +$5.27K ﹤0.01% 548
2024
Q1
$6.01K Buy
64
+14
+28% +$1.13K ﹤0.01% 600
2023
Q4
$3.67K Buy
+50
New +$3.2K ﹤0.01% 620

Other funds holding BRKR

Castleview Partners's BRKR Position: Q4 2024 in Review

Castleview Partners sold out of Bruker (BRKR) in Q4 2024, closing a stake of 191 shares — an estimated $13.2K sold.

Castleview Partners first reported a position in BRKR in Q4 2023 and held it in 4 quarters. The position peaked at $13.2K in Q3 2024. 367 funds tracked by Wall St. Rank hold BRKR as of Q4 2024.

  • Castleview Partners reported no remaining Bruker position as of Q4 2024 after selling out during the quarter.
  • Castleview Partners sold 191 Bruker shares in Q4 2024, an estimated $13.2K.
  • Castleview Partners first reported a position in Bruker in Q4 2023 and held it in 4 quarters.
  • Castleview Partners's Bruker position peaked at $13.2K in Q3 2024.
  • 367 funds tracked by Wall St. Rank held Bruker as of Q4 2024.

Based on Castleview Partners's 13F filing for Q4 2024, filed 21 Jan 2025.